Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-20 22:13:30 UTC |
---|
Update Date | 2022-03-07 02:49:10 UTC |
---|
HMDB ID | HMDB0001830 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Progesterone |
---|
Description | The major progestational steroid that is secreted primarily by the corpus luteum and the placenta. Progesterone acts on the uterus, the mammary glands and the brain. It is required in embryo implantation, pregnancy maintenance, and the development of mammary tissue for milk production. Progesterone, converted from pregnenolone, also serves as an intermediate in the biosynthesis of gonadal steroid hormones and adrenal corticosteroids. Progesterone is a C-21 steroid hormone involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of humans and other species. Progesterone belongs to a class of hormones called progestagens, and is the major naturally occurring human progestagen. During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy. Progesterone decreases contractility of the uterine smooth muscle. The fetus metabolizes placental progesterone in the production of adrenal mineralo- and glucosteroids. A drop in progesterone levels is possibly one step that facilitates the onset of labor. In addition progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production. Progesterone is found to be associated with pregnene hydroxylation deficiency, which is an inborn error of metabolism. |
---|
Structure | [H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1 |
---|
Synonyms | Value | Source |
---|
(S)-4-Pregnene-3,20-dione | ChEBI | (S)-Pregn-4-en-3,20-dione | ChEBI | (S)-Progesterone | ChEBI | 17alpha-Progesterone | ChEBI | 4-Pregnene-3,20-dione | ChEBI | Agolutin | ChEBI | Akrolutin | ChEBI | Corpus luteum hormone | ChEBI | Crinone | ChEBI | Delta(4)-Pregnene-3,20-dione | ChEBI | Gelbkoerperhormon | ChEBI | Luteohormone | ChEBI | Progesteron | ChEBI | Prometrium | Kegg | 17a-Progesterone | Generator | 17Α-progesterone | Generator | Δ(4)-pregnene-3,20-dione | Generator | 3,20-Pregnene-4 | HMDB | 4-Pregnen-3,20-dione | HMDB | beta-Progesterone | HMDB | Bio-luton | HMDB | CIDR | HMDB | Colprosterone | HMDB | Corlutin | HMDB | Corlutina | HMDB | Corluvite | HMDB | Corporin | HMDB | Crinone progesterone gel | HMDB | Curretab | HMDB | Cyclogest | HMDB | Cyclogesterin | HMDB | D4-Pregnene-3,20-dione | HMDB | Delalutin | HMDB | Duraprogen | HMDB | Estima | HMDB | Flavolutan | HMDB | Fologenon | HMDB | Gesterol | HMDB | Gesterol 100 | HMDB | Gesterol 50 | HMDB | Gestiron | HMDB | Gestone | HMDB | Gestormone | HMDB | Gestron | HMDB | Glanducorpin | HMDB | Gynlutin | HMDB | Gynoluton | HMDB | Gynolutone | HMDB | Hormoflaveine | HMDB | Hormoluton | HMDB | Hydroxyprogesterone caproate | HMDB | Hydroxyprogesterone caproic acid | HMDB | Lingusorbs | HMDB | Lipo-lutin | HMDB | Lucorteum | HMDB | Lucorteum sol | HMDB | Lugesteron | HMDB | Luteal hormone | HMDB | Luteocrin normale | HMDB | Luteodyn | HMDB | Luteogan | HMDB | Luteol | HMDB | Luteopur | HMDB | Luteosan | HMDB | Luteostab | HMDB | Luteovis | HMDB | Luteum | HMDB | Lutex | HMDB | Lutidon | HMDB | Lutociclina | HMDB | Lutocuclin m | HMDB | Lutocyclin | HMDB | Lutocyclin m | HMDB | Lutocylin | HMDB | Lutocylol | HMDB | Lutoform | HMDB | Lutogyl | HMDB | Lutren | HMDB | Lutromone | HMDB | Membrettes | HMDB | Methylpregnone | HMDB | MPA | HMDB | Nalutron | HMDB | Percutacrine | HMDB | Percutacrine luteinique | HMDB | Piaponon | HMDB | Pranone | HMDB | Pregn-4-en-3,20-dione | HMDB | Pregn-4-ene-3,20-dione | HMDB | Pregnene-3,20-dione | HMDB | Pregnenedione | HMDB | Primolut | HMDB | Prochieve | HMDB | Progeffik | HMDB | Progekan | HMDB | Progestan | HMDB | Progestasert | HMDB | Progesterol | HMDB | Progesteronum | HMDB | Progestin | HMDB | Progestogel | HMDB | Progestol | HMDB | Progeston | HMDB | Progestone | HMDB | Progestosol | HMDB | Progestron | HMDB | Progestronol | HMDB | Projestaject | HMDB | Prolets | HMDB | Prolidon | HMDB | Prolutin | HMDB | Proluton | HMDB | Prolutone | HMDB | Prontogest | HMDB | Protormone | HMDB | Syngesterone | HMDB | Syngestrets | HMDB | Synovex S | HMDB | Syntolutan | HMDB | Utrogest | HMDB | Utrogestan | HMDB | Vitarrine | HMDB | Progesterone, (13 alpha,17 alpha)-(+-)-isomer | HMDB | Progesterone, (17 alpha)-isomer | HMDB | Progesterone, (9 beta,10 alpha)-isomer | HMDB |
|
---|
Chemical Formula | C21H30O2 |
---|
Average Molecular Weight | 314.4617 |
---|
Monoisotopic Molecular Weight | 314.224580204 |
---|
IUPAC Name | (1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
Traditional Name | (1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
CAS Registry Number | 57-83-0 |
---|
SMILES | [H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1 |
---|
InChI Key | RJKFOVLPORLFTN-LEKSSAKUSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Pregnane steroids |
---|
Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 20-oxosteroid
- Oxosteroid
- 3-oxosteroid
- 3-oxo-delta-4-steroid
- Delta-4-steroid
- Cyclohexenone
- Cyclic ketone
- Ketone
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 121 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0088 mg/mL at 25 °C | YALKOWSKY,SH & DANNENFELSER,RM (1992) | LogP | 3.87 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Progesterone,1TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 2935.8 | Semi standard non polar | 33892256 | Progesterone,1TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 2761.9 | Standard non polar | 33892256 | Progesterone,1TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 3115.6 | Standard polar | 33892256 | Progesterone,1TMS,isomer #2 | CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 2806.8 | Semi standard non polar | 33892256 | Progesterone,1TMS,isomer #2 | CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 2736.3 | Standard non polar | 33892256 | Progesterone,1TMS,isomer #2 | CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3129.0 | Standard polar | 33892256 | Progesterone,1TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 2910.0 | Semi standard non polar | 33892256 | Progesterone,1TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 2742.5 | Standard non polar | 33892256 | Progesterone,1TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 3219.6 | Standard polar | 33892256 | Progesterone,2TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 2873.1 | Semi standard non polar | 33892256 | Progesterone,2TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 2826.7 | Standard non polar | 33892256 | Progesterone,2TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3154.4 | Standard polar | 33892256 | Progesterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 2853.8 | Semi standard non polar | 33892256 | Progesterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 2814.3 | Standard non polar | 33892256 | Progesterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3245.2 | Standard polar | 33892256 | Progesterone,1TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 3169.8 | Semi standard non polar | 33892256 | Progesterone,1TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 3011.2 | Standard non polar | 33892256 | Progesterone,1TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 3275.5 | Standard polar | 33892256 | Progesterone,1TBDMS,isomer #2 | CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3057.6 | Semi standard non polar | 33892256 | Progesterone,1TBDMS,isomer #2 | CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 2961.4 | Standard non polar | 33892256 | Progesterone,1TBDMS,isomer #2 | CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3273.8 | Standard polar | 33892256 | Progesterone,1TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 3154.2 | Semi standard non polar | 33892256 | Progesterone,1TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 3002.7 | Standard non polar | 33892256 | Progesterone,1TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | 3363.3 | Standard polar | 33892256 | Progesterone,2TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3348.2 | Semi standard non polar | 33892256 | Progesterone,2TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3269.7 | Standard non polar | 33892256 | Progesterone,2TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3394.4 | Standard polar | 33892256 | Progesterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3360.6 | Semi standard non polar | 33892256 | Progesterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3257.9 | Standard non polar | 33892256 | Progesterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C | 3458.6 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Progesterone GC-MS (Non-derivatized) | splash10-0fbc-5910000000-422e38df6de7e8b0a4b7 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Progesterone GC-MS (Non-derivatized) | splash10-0fbc-5910000000-385f45345742235da8e0 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Progesterone EI-B (Non-derivatized) | splash10-024l-6923000000-639c7405f69825de7f90 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Progesterone EI-B (Non-derivatized) | splash10-0229-2941000000-1e075d8489b79cf4e34a | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Progesterone EI-B (Non-derivatized) | splash10-0229-3963000000-f35e3d9faf6b2ee87465 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Progesterone GC-MS (Non-derivatized) | splash10-0fbc-5910000000-422e38df6de7e8b0a4b7 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Progesterone GC-MS (Non-derivatized) | splash10-0fbc-5910000000-385f45345742235da8e0 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Progesterone GC-EI-TOF (Non-derivatized) | splash10-0f6x-2910000000-1baafb91a3e0b988caa7 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Progesterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-000g-1590000000-3ebb52b90c541e38c0b4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Progesterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-006x-7931000000-f6ad83adccd7e016fa29 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-014i-1009000000-0f8b7c3e6c2265c3889f | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-052b-8900000000-0b0167121b798e7e7534 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-052b-9400000000-881510cbcecd9cb61f4f | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone EI-B (JEOL JMS-01-SG-2) , Positive-QTOF | splash10-024l-6923000000-639c7405f69825de7f90 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone EI-B (HITACHI M-52) , Positive-QTOF | splash10-0229-2941000000-1e075d8489b79cf4e34a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-qTof , Positive-QTOF | splash10-004i-0950000000-ca28d8dfdf780c201716 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-qTof , Positive-QTOF | splash10-000i-1900000000-857f6720dd17fb2547d1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-qTof , Positive-QTOF | splash10-004i-3930000000-fda87095285a83b85ad5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QTOF , positive-QTOF | splash10-00kb-7955000000-a22f06eac940cd4f753d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QTOF , positive-QTOF | splash10-014i-0139000000-6b47f75a44df3e20fa3b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QTOF , positive-QTOF | splash10-0aba-0950000000-b26d04d179294aa67cc7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QTOF , positive-QTOF | splash10-0aba-0920000000-d0a3365efe1f8a589564 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QTOF , positive-QTOF | splash10-05aj-0910000000-61d7a07e6be85600e1f1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QTOF , positive-QTOF | splash10-014i-0009000000-67c6f0147801f0ece957 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QFT , positive-QTOF | splash10-05mk-8956000000-aa5fe992c41261b62fbf | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QFT , positive-QTOF | splash10-052b-6910000000-5e26497eb2d0150a30ac | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QFT , positive-QTOF | splash10-0a4j-8900000000-7ca6fd15f0ccc18bfa31 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QFT , positive-QTOF | splash10-052b-9700000000-523fe1ad11bfcbb46f85 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Progesterone LC-ESI-QFT , positive-QTOF | splash10-054k-9400000000-e3d581bd8685e1d3f35d | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Progesterone 10V, Positive-QTOF | splash10-014i-0269000000-9aa25f8d44bc44ee4d4c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Progesterone 20V, Positive-QTOF | splash10-06dj-0491000000-c312ac322a549be24fac | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Progesterone 40V, Positive-QTOF | splash10-0pbc-2290000000-859101eb546be9ddc938 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Progesterone 10V, Negative-QTOF | splash10-03di-0019000000-e021f799bd2d232a0592 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Progesterone 20V, Negative-QTOF | splash10-03di-0049000000-55066424591bf87a4a49 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Progesterone 40V, Negative-QTOF | splash10-0002-1090000000-e9387b8ab692f5ef9083 | 2017-07-26 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane (predicted from logP)
- Endoplasmic reticulum
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
---|
Tissue Locations | - Adipose Tissue
- Fibroblasts
- Neuron
- Ovary
- Placenta
- Platelet
- Prostate
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.000320 - 0.0795 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0 - 0.000320 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.00267-0.0432 uM | Newborn (0-30 days old) | Female | Normal | | details | Blood | Detected and Quantified | 0.0019 (0.0-0.0038) uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.0020 (0.00-0.0045) uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.049 (0.008-0.089) uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.001 (0.00- 0.0022) uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0042 uM | Infant (4 days - <1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0011 uM | Children (1 - <10 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00041-0.0027 uM | Adolescent (10 - <15 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00064-0.033 uM | Adolescent (15 - <19 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.00051-0.0018 uM | Adolescent (15 - <19 years old) | Male | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.000300-0.00240 uM | Infant (0-1 year old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.0025 +/- 0.0005 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.035 +/-0.0184 uM | Adult (>18 years old) | Female | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.001 (0.00002-0.002) uM | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | <0.000318 uM | Newborn (0-30 days old) | Female | Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete | | details | Blood | Detected and Quantified | 0.00191-0.115 uM | Newborn (0-30 days old) | Male | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.0006 (0.0003-0.001) uM | Adult (>18 years old) | Both | Pregnene hydroxylation deficiency | | details | Blood | Detected and Quantified | 0.089 (0.029-0.150) uM | Adult (>18 years old) | Female | Pregnancy | | details | Blood | Detected and Quantified | 0.259 (0.054-0.464) uM | Adult (>18 years old) | Female | Pregnancy | | details | Blood | Detected and Quantified | 0.493 (0.175-0.811) uM | Adult (>18 years old) | Female | Pregnancy | | details | Blood | Detected and Quantified | 0.00223 uM | Adult (>18 years old) | Female | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Schizophrenia | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Schizophrenia | | details | Blood | Detected and Quantified | 0.0108-0.119 uM | Infant (0-1 year old) | Both | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | | details | Blood | Detected and Quantified | 0.0025 +/- 0.0017 uM | Adult (>18 years old) | Both | Psychiatric disorder | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Pregnancy |
---|
- (). The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.. .
| Alcoholism |
---|
- Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR: Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):309-14. Epub 2006 Sep 7. [PubMed:16959481 ]
| Major depressive disorder |
---|
- Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR: Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):309-14. Epub 2006 Sep 7. [PubMed:16959481 ]
| Pregnene hydroxylation deficiency |
---|
- Shackleton C, Malunowicz E: Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome. Steroids. 2003 Oct;68(9):707-17. [PubMed:14625002 ]
| Schizophrenia |
---|
- Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24. [PubMed:22944140 ]
| Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency |
---|
- Hattori N, Ishihara T, Moridera K, Hino M, Ikekubo K, Kurahachi H: A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency. Endocr J. 1993 Feb;40(1):107-9. [PubMed:7951484 ]
- Guven A, Polat S: Testicular Adrenal Rest Tumor in Two Brothers with a Novel Mutation in the 3-Beta-Hydroxysteroid Dehydrogenase-2 Gene. J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):85-90. doi: 10.4274/jcrpe.3306. Epub 2016 Jul 29. [PubMed:27476613 ]
| Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
---|
- Fukami M, Hasegawa T, Horikawa R, Ohashi T, Nishimura G, Homma K, Ogata T: Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatr Res. 2006 Feb;59(2):276-80. doi: 10.1203/01.pdr.0000195825.31504.28. [PubMed:16439592 ]
| Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete |
---|
- Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL: Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab. 2008 Mar;93(3):696-702. doi: 10.1210/jc.2007-2330. Epub 2008 Jan 8. [PubMed:18182448 ]
|
|
---|
Associated OMIM IDs | - 608516 (Major depressive disorder)
- 181500 (Schizophrenia)
- 201810 (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency)
- 201750 (Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis)
- 613743 (Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete)
|
---|
External Links |
---|
DrugBank ID | DB00396 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB001871 |
---|
KNApSAcK ID | C00034649 |
---|
Chemspider ID | 5773 |
---|
KEGG Compound ID | C00410 |
---|
BioCyc ID | PROGESTERONE |
---|
BiGG ID | 34898 |
---|
Wikipedia Link | Progesterone |
---|
METLIN ID | 402 |
---|
PubChem Compound | 5994 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 17026 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | PRGSTRN |
---|
MarkerDB ID | MDB00000342 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Vasquez, L.; Alarcon, J.; Zunza, H.; Becerra, J.; Silva, M. Chemical-microbiological synthesis of progesterone. Boletin de la Sociedad Chilena de Quimica (2001), 46(1), 29-31. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Pierson-Mullany LK, Lange CA: Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol Cell Biol. 2004 Dec;24(24):10542-57. [PubMed:15572662 ]
- Callaghan MJ, Russell AJ, Woollatt E, Sutherland GR, Sutherland RL, Watts CK: Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene. 1998 Dec 31;17(26):3479-91. [PubMed:10030672 ]
- Schwarz S, Pohl P: Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier. Neuroendocrinology. 1992 Feb;55(2):174-82. [PubMed:1620285 ]
- Afsar NA, Barakzai Q, Adil SN: Effect of a 'progestin only' contraceptive on platelet aggregation in a Pakistani set of population. J Ayub Med Coll Abbottabad. 2005 Jul-Sep;17(3):21-5. [PubMed:16320790 ]
- Moguilewsky M, Tournemine C: The antiandrogen anandron potentiates the castrating effect of the LH-RH agonist buserelin in the rat. Am J Clin Oncol. 1988;11 Suppl 2:S148-51. [PubMed:3149454 ]
- Wang C, Swerdloff RS: Male hormonal contraception. Am J Obstet Gynecol. 2004 Apr;190(4 Suppl):S60-8. [PubMed:15105800 ]
- Landi N, Manfredini D, Lombardi I, Casarosa E, Bosco M: 17-beta-estradiol and progesterone serum levels in temporomandibular disorder patients. Minerva Stomatol. 2004 Nov-Dec;53(11-12):651-60. [PubMed:15894940 ]
- Classen-Linke I, Alfer J, Krusche CA, Chwalisz K, Rath W, Beier HM: Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture. Steroids. 2000 Oct-Nov;65(10-11):763-71. [PubMed:11108887 ]
- Casey ML, MacDonald PC, Andersson S: 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest. 1994 Nov;94(5):2135-41. [PubMed:7962560 ]
- Lueprasitsakul P, Longcope C: Aromatase activity of human adipose tissue stromal cells: effects of thyroid hormones and progestogens. Proc Soc Exp Biol Med. 1990 Sep;194(4):337-41. [PubMed:2167478 ]
- Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, Thiebaut A, Tjonneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E: Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2005 May 18;97(10):755-65. [PubMed:15900045 ]
- Oliveira RL, Aldrighi JM, Gebara OE, Rocha TR, D'Amico E, Rosano GM, Ramires JA: Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2. Int J Cardiol. 2005 Mar 30;99(3):449-54. [PubMed:15771927 ]
- Magee JA, Chang LW, Stormo GD, Milbrandt J: Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology. 2006 Jan;147(1):590-8. Epub 2005 Oct 6. [PubMed:16210365 ]
- Baum LW: Sex, hormones, and Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2005 Jun;60(6):736-43. [PubMed:15983176 ]
- Seibert B, Gunzel P: Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna. Contraception. 1994 Apr;49(4):303-33. [PubMed:8013217 ]
- Payer AF, Meyer WJ 3rd, Walker PA: The ultrastructural response of human Leydig cells to exogenous estrogens. Andrologia. 1979;11(6):423-36. [PubMed:532984 ]
- Hould FS, Fried GM, Fazekas AG, Tremblay S, Mersereau WA: Progesterone receptors regulate gallbladder motility. J Surg Res. 1988 Dec;45(6):505-12. [PubMed:3184927 ]
- Allen WM: Progesterone: how did the name originate? South Med J. 1970 Oct;63(10):1151-5. [PubMed:4922128 ]
- Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF: Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S18-33. [PubMed:15135772 ]
- Allen WM: THE ISOLATION OF CRYSTALLINE PROGESTIN. Science. 1935 Aug 2;82(2118):89-93. [PubMed:17747122 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|